Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody
about
Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.Dendritic cells in islets of Langerhans constitutively present beta cell-derived peptides bound to their class II MHC moleculesHuman islet cell transplantation--future prospects.Antibody-functionalized peptidic membranes for neutralization of allogeneic skin antigen-presenting cells.Low-temperature culture of human islets or in vivo treatment with L3T4 antibody produces a marked prolongation of islet human-to-mouse xenograft survivalIslet xenografts in fully xenogeneic (rat----mouse) chimeras: evidence for normal regulation of function in a xenogeneic mouse environmentInitial in vivo experience of pig artery patch transplantation in baboons using mutant MHC (CIITA-DN) pigsT-lymphocytes and the pathogenesis of type 1 (insulin-dependent) diabetes mellitus.Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo.Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine releaseMurine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro.Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection.Animals bearing malignant grafts reject normal grafts that express through gene transfer the same antigen.Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleuraDendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situMigration patterns of dendritic cells in the mouse. Traffic from the blood, and T cell-dependent and -independent entry to lymphoid tissues.Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses.Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo.Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo.Immunotoxin Against a Donor MHC Class II Molecule Induces Indefinite Survival of Murine Kidney Allografts.CD8(+) T cells resistant to costimulatory blockade are controlled by an antagonist interleukin-15/Fc protein.Properties of memory T lymphocytes isolated from the mixed leukocyte reaction.Replication of human immunodeficiency virus type 1 in primary dendritic cell culturesInterstitial dendritic cells.Dendritic cells as antigen presenting cells in vivo.Antigen presentation events in autoimmune diabetes.New concepts of immune modulation in xenotransplantation.The Mononuclear Phagocyte System in Organ Transplantation.Management of High-risk Corneal Transplantation.Transplantation in diabetes: a cell biological problem.Induction of Pancreatic Islet Graft Acceptance: The Role of Antigen Presenting CellsDepletion of passenger leukocytes from corneal grafts: an effective means of promoting transplant survival?Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed and sensitized T lymphocytes.Stimulation of mature unprimed CD8+ T cells by semiprofessional antigen-presenting cells in vivo.Cellular composition of islet cell suspensions for transplantation.Activation of intraislet lymphoid cells causes destruction of islet cells.Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cells.Long-term survival of donor-specific pancreatic islet xenografts in fully xenogeneic chimeras (WF rat----B10 mouse)Composition of human islet cell preparations for transplantation.Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody.
P2860
Q30437086-8AC00B1A-2D42-4508-BDB6-B03C92D18462Q30481754-D116D7ED-5DD6-47B7-A2B0-10DEA1A3287FQ34184785-821E0D15-CCD4-4FBE-AF1A-BE736B13D697Q34294622-C941D111-EA3B-4927-B79E-C9BBBEA1FC69Q34366549-80E77798-C87C-406B-A40C-F9A12839226AQ34498247-A578BE05-A6CF-47CC-B3A2-B2092D905387Q35202459-F3566E0A-A055-4824-8851-B9B4F62CEE19Q35654189-469A87D8-CE0B-46D2-AF58-FA55F3BE6D53Q36230770-5033D8ED-545B-4F25-86F7-B6D69EC44EB0Q36349639-77A41EF3-DFC1-41B9-B39E-72FA9FDA6229Q36349915-2CEB7242-993C-4932-AB2B-2B8713B9290DQ36350198-EF45D86E-23E5-4D6F-A0D1-B7A6F19A6DA7Q36350930-1BF754D4-4A77-4FFF-AB79-5FDE24C78272Q36351551-3D54B9CA-A036-4755-8D9D-AA37407A3F78Q36352646-94D14FB2-4027-473B-9B36-E5BEE23D3005Q36354492-964422A1-CCB3-4250-9E08-A1749A364DECQ36362098-366E4175-7892-4E0F-A102-29A0C76F611FQ36362128-6B4EBA2D-FBCE-4936-B926-0C5ECCC4D9AAQ36367475-F2DCB00C-87FC-424E-9B7C-6FF6C5CF881FQ37183450-3F40BDD4-2CAA-4812-B5E6-6EA23B2A40C3Q37190095-76484830-727E-4DB0-9C48-605D8362DA5EQ37555446-8FD2D2A4-44C8-46C2-A17B-A4B97B4B5E54Q37592488-8C991A08-3A03-4D84-8798-C17522F2293BQ37869628-5B48F162-DFEE-4DA5-8A27-57FEE8C8FABDQ37869637-7F94916E-BB6A-430B-B492-F3700C04EC4AQ37969489-2B6ED14A-53DE-4F81-86D8-9C03FE85615EQ38121442-F986786F-ED51-4AA5-BF56-35FD1CD4CEE5Q38646389-C043A67E-5FAA-41D5-A4CD-A2CC5934CE49Q38778422-B359DB05-2CC7-49DE-8ADF-F3AA2359FC4BQ40414447-ECDD1022-30CE-4C56-A269-1F7A5AD3869AQ41770384-AAD06F3D-E57C-41F4-828F-12162C799B7AQ41786670-865E1A3D-10BE-4AE2-9E30-D0DAA4891FACQ41819359-D2200462-C533-490A-B972-E6D0A3173080Q41882660-B925F629-576E-43BA-8583-A093D41E8417Q41904965-571877B6-812F-4D01-B903-790BCB733D49Q41931796-5FD10F75-DE21-4929-B767-D4169A7CB6A3Q42049156-68A91CC5-EE9A-40D7-967C-AC952BD7216DQ42107608-52E6DA1C-0652-41B3-8781-F609024ABDC9Q42410922-6529F44D-4A81-4300-9372-E5E7977EADADQ42937985-2B847AC4-CE72-4220-9B11-1CF807A4B1C3
P2860
Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh
1984年學術文章
@zh-hant
name
Prevention of rejection of mur ...... h anti-dendritic cell antibody
@ast
Prevention of rejection of mur ...... h anti-dendritic cell antibody
@en
type
label
Prevention of rejection of mur ...... h anti-dendritic cell antibody
@ast
Prevention of rejection of mur ...... h anti-dendritic cell antibody
@en
prefLabel
Prevention of rejection of mur ...... h anti-dendritic cell antibody
@ast
Prevention of rejection of mur ...... h anti-dendritic cell antibody
@en
P2093
P2860
P356
P1476
Prevention of rejection of mur ...... h anti-dendritic cell antibody
@en
P2093
D L Faustman
R M Steinman
V Hauptfeld
P2860
P304
P356
10.1073/PNAS.81.12.3864
P407
P577
1984-06-01T00:00:00Z